Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-19

Clinical Trial Update: Examining The Role of CGM in T2DM [NA]

View source ↗

Summary

This clinical trial update reports on a study examining the role of continuous glucose monitoring in type 2 diabetes mellitus. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • continuous glucose monitor (CGM)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder) | NA | Status: COMPLETED